Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes
D Guo, Q Liu, T Liu, G Elliott, M Gingras… - Journal of …, 2011 - journals.lww.com
Abstract HBI-3000 (sulcardine sulfate) has been shown to suppress various ventricular
arrhythmias in animal models. The electrophysiological properties of HBI-3000 were …
arrhythmias in animal models. The electrophysiological properties of HBI-3000 were …
Pharmacokinetics, safety, and tolerability of sulcardine sulfate: an open‐label, single‐dose, randomized study in healthy Chinese subjects
Q Chen, H Qian, W Wang, M Zhang… - Fundamental & …, 2017 - Wiley Online Library
Sulcardine sulfate (Sul) is a novel anti‐arrhythmic agent as a potential treatment for atrial
fibrillation and ventricular arrhythmias. This study was conducted to investigate the …
fibrillation and ventricular arrhythmias. This study was conducted to investigate the …
[HTML][HTML] Multiple dose pharmacokinetics and safety of Sulcardine sulfate in healthy Chinese male subjects: an open-label phase I clinical study
W Wang, H Qian, L Xin, M Zhang, D Lu, J Jin… - European Journal of …, 2017 - Springer
Background Sulcardine sulfate is a novel antiarrhythmic agent with mechanism of action as
a multi-ion channel blocker. Preclinical studies in animal models have demonstrated that …
a multi-ion channel blocker. Preclinical studies in animal models have demonstrated that …